NCT06333028View on ClinicalTrials.gov

A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

May 30, 2024

Primary Completion Date

March 13, 2025

Study Completion Date

March 13, 2025

Conditions

Cataract

Interventions

DEVICE

enVista Aspire EA IOLs

Subjects bilaterally implanted with enVista Aspire EA IOLs

Trial Locations (7)

11530

Site 103, Garden City

16066

Site 107, Cranberry Township

29407

Site 106, Charleston

53405

Site 102, Mount Pleasant

77478

Site 101, Sugar Land

07801

SITE 104, Dover

07424

Site 105, Woodland Park

All Listed Sponsors

lead

Bausch & Lomb Incorporated

INDUSTRY

NCT06333028 - A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction | Biotech Hunter | Biotech Hunter